F Massoud1, G Devi, Y Stern, A Lawton, J E Goldman, Y Liu, S S Chin, R Mayeux. 1. Gertrude H Sergievsky Center, Columbia University College of Physicians and Surgeons and Columbia-Presbyterian Medical Center, New York, NY 10032, USA. rpm2@columbia.edu
Abstract
OBJECTIVES: To compare the sensitivity and specificity of the clinical diagnosis of Alzheimer disease, the distribution of pathological causes, and the demographic and clinical characteristics of 2 different groups of patients with dementia. DESIGN: Retrospective clinicopathological study. SETTING: A memory disorder clinic in a university hospital and a multiethnic community. PATIENTS: Sixty-three patients from a memory disorder clinic and 26 patients from a large community-based study who underwent autopsy after clinical evaluation. MAIN OUTCOME MEASURES: Differential distribution of clinical and pathological findings, with clinicopathological correlations. RESULTS: Clinic patients were younger at diagnosis, more educated, and more likely to be white. Of the 63 clinic patients we evaluated, 29 (46%) had a pathological diagnosis of definite AD, 15 (24%) had a diagnosis of mixed AD, and 19 (30%) had a diagnosis of another type of dementia. The pathological diagnoses in the community patients were distributed as follows: 6 (23%) had definite AD, 6 (23%) had mixed AD, 6 (23%) had cerebrovascular disease, and 8 (31%) had another type of dementia. The difference in distribution of pathological diagnoses between these 2 groups was only significant for cerebrovascular diseases. For patients seen at the clinic, the sensitivity of the clinical diagnosis of AD was 98% and the specificity was 84%; for the community group, the sensitivity was 92% and the specificity was 79%. CONCLUSIONS: The difference in sensitivity and specificity of clinical diagnosis was not statistically significant between the groups of clinic patients and community patients. Dementia associated with cerebrovascular disease was more prevalent in the community sample. This difference may be attributable to clinical and demographic differences between the 2 groups.
OBJECTIVES: To compare the sensitivity and specificity of the clinical diagnosis of Alzheimer disease, the distribution of pathological causes, and the demographic and clinical characteristics of 2 different groups of patients with dementia. DESIGN: Retrospective clinicopathological study. SETTING:A memory disorder clinic in a university hospital and a multiethnic community. PATIENTS: Sixty-three patients from a memory disorder clinic and 26 patients from a large community-based study who underwent autopsy after clinical evaluation. MAIN OUTCOME MEASURES: Differential distribution of clinical and pathological findings, with clinicopathological correlations. RESULTS: Clinic patients were younger at diagnosis, more educated, and more likely to be white. Of the 63 clinic patients we evaluated, 29 (46%) had a pathological diagnosis of definite AD, 15 (24%) had a diagnosis of mixed AD, and 19 (30%) had a diagnosis of another type of dementia. The pathological diagnoses in the community patients were distributed as follows: 6 (23%) had definite AD, 6 (23%) had mixed AD, 6 (23%) had cerebrovascular disease, and 8 (31%) had another type of dementia. The difference in distribution of pathological diagnoses between these 2 groups was only significant for cerebrovascular diseases. For patients seen at the clinic, the sensitivity of the clinical diagnosis of AD was 98% and the specificity was 84%; for the community group, the sensitivity was 92% and the specificity was 79%. CONCLUSIONS: The difference in sensitivity and specificity of clinical diagnosis was not statistically significant between the groups of clinic patients and community patients. Dementia associated with cerebrovascular disease was more prevalent in the community sample. This difference may be attributable to clinical and demographic differences between the 2 groups.
Authors: D W Tsuang; R K Wilson; O L Lopez; E K Luedecking-Zimmer; J B Leverenz; S T DeKosky; M I Kamboh; R L Hamilton Journal: Neurology Date: 2005-02-08 Impact factor: 9.910
Authors: Joshua A Sonnen; Karen Santa Cruz; Laura S Hemmy; Randall Woltjer; James B Leverenz; Kathleen S Montine; Clifford R Jack; Jeffrey Kaye; Kelvin Lim; Eric B Larson; Lon White; Thomas J Montine Journal: Arch Neurol Date: 2011-08
Authors: JoAnn T Tschanz; Chris D Corcoran; Sarah Schwartz; Katherine Treiber; Robert C Green; Maria C Norton; Michelle M Mielke; Kathleen Piercy; Martin Steinberg; Peter V Rabins; Jeanne-Marie Leoutsakos; Kathleen A Welsh-Bohmer; John C S Breitner; Constantine G Lyketsos Journal: Am J Geriatr Psychiatry Date: 2011-06 Impact factor: 4.105
Authors: Jesse Mez; Jaeyoon Chung; Gyungah Jun; Joshua Kriegel; Alexandra P Bourlas; Richard Sherva; Mark W Logue; Lisa L Barnes; David A Bennett; Joseph D Buxbaum; Goldie S Byrd; Paul K Crane; Nilüfer Ertekin-Taner; Denis Evans; M Daniele Fallin; Tatiana Foroud; Alison Goate; Neill R Graff-Radford; Kathleen S Hall; M Ilyas Kamboh; Walter A Kukull; Eric B Larson; Jennifer J Manly; Jonathan L Haines; Richard Mayeux; Margaret A Pericak-Vance; Gerard D Schellenberg; Kathryn L Lunetta; Lindsay A Farrer Journal: Alzheimers Dement Date: 2016-10-20 Impact factor: 21.566
Authors: Sudha Seshadri; Alexa Beiser; Rhoda Au; Philip A Wolf; Denis A Evans; Robert S Wilson; Ronald C Petersen; David S Knopman; Walter A Rocca; Claudia H Kawas; Maria M Corrada; Brenda L Plassman; Kenneth M Langa; Helena C Chui Journal: Alzheimers Dement Date: 2011-01 Impact factor: 21.566
Authors: Stephen A Back; Christopher D Kroenke; Larry S Sherman; Gus Lawrence; Xi Gong; Erin N Taber; Joshua A Sonnen; Eric B Larson; Thomas J Montine Journal: Ann Neurol Date: 2011-09 Impact factor: 10.422
Authors: Susan M Landau; Mark A Mintun; Abhinay D Joshi; Robert A Koeppe; Ronald C Petersen; Paul S Aisen; Michael W Weiner; William J Jagust Journal: Ann Neurol Date: 2012-10 Impact factor: 10.422